Skip to main content
Premium Trial:

Request an Annual Quote

Seegene Partners With Institut Català d'Oncologia on Cancer Dx Research

This article has been updated to correct the timing of US approval for Seegene's first molecular diagnostic.

NEW YORK (GenomeWeb) – Seegene announced today that it has formed a cancer diagnostics research and development alliance with Spain's Institut Català d'Oncologia (ICO).

Under the terms of the deal, ICO will help Seegene conduct studies of its molecular diagnostic products using clinical specimens, and develop new cancer diagnostic products. According to the company, the partnership marks the first step in its so-called Project 100: One platform MDx Solution — a plan to develop 100 new molecular diagnostics within the next two years.

Last year, Seegene received US approval for its first molecular diagnostic — an assay for herpes simplex virus I and II that uses the company's TOCE primer technology for multiplexed real-time PCR.

"It is very encouraging to build [a] partnership with the ICO for clinical evaluation of Seegene's products as the first step toward successful implementation of Project 100," Seegene CEO Jong-Yoon Chun said in a statement. "It is expected to reduce the period of product development and clinical research that have demanded considerable costs and research manpower for a long time."

The South Korean company said that it is actively looking for additional clinical research partners around the world.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.